Diethylcarbamazine

This classification denotes an antihelminthic agent with the molecular formula C10H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V867Q8X3ZD, chemically known as 4-methyl-n,n-bis(4-methylpiperazin-2-yl)-piperazine-1-carboxamide but generally known as diethylcarbamazine, which bears US NIH Compound Identifier 3052. European Medicines Agency schedules Diethylcarbamazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07111MIG. The term DIETHYLCARBAMAZINE is an International Non-Proprietary Name. World Health Organization schedules diethylcarbamazine in its Anatomical Therapeutic Chemical (ATC) Classification. DIETHYLCARBAMAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diethylcarbamazine under HS 29335995 and SITC 51576. As of Q4 2014, DIETHYLCARBAMAZINE remains the US FDA Preferred Term for this commodity. Diethylcarbamazine bears US NLM identifiers UMLS ID C0012191 and NCI Concept Code C65378. SMILES: CCN(CC)C(=O)N1CCN(CC1)C.